Prostaglandins produced by the COX-2 isoform of cyclooxygenase may be important for renal function--and perhaps even more so in diseases that render the kidney highly prostaglandin-dependent. COX-2 inhibitors may thus have much the same renal risks that a standard NSAID does. Several clinical trials have already focused on the new drugs' renal effects.
No takes yet. Share an insight, caveat, or question.
Mark A. Perazella (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: